Philips (PHG) announced it has received FDA 510(k) clearance for EchoNavigator R5.0 with DeviceGuide, an AI-powered software solution that assists physicians during one of interventional cardiology’s most technically demanding procedures – repairing leaking mitral valves through a minimally invasive approach.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHG:
- Philips launches IntraSight Plus
- Philips removed from European Conviction List at Goldman Sachs
- Royal Philips Files 2025 Annual Report Highlighting Growth, Cash Generation and ESG Progress
- Philips price target raised to EUR 26 from EUR 25 at Morgan Stanley
- Philips introduces InkSpace Imaging’s Snuggle flexible pediatric MRI coil